State Of Tennessee, Treasury Department Regeneron Pharmaceuticals, Inc. Transaction History

State Of Tennessee, Treasury Department

$27.8 Billion
Q3 2024

A detailed history of State Of Tennessee, Treasury Department transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 38,861 shares of REGN stock, worth $27.7 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

38,861

Previous 42,907 9.43%

Holding current value

$27.7 Million

Previous $45.1 Million 9.41%

% of portfolio

0.15%

Previous 0.17%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $4.14 Million - $4.86 Million	-4,046 Reduced 9.43%	38,861 $40.9 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $2.07 Million - $2.51 Million	-2,339 Reduced 5.17%	42,907 $45.1 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $2.72 Million - $3 Million	-3,018 Reduced 6.25%	45,246 $43.5 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $15.4 Million - $17.5 Million	19,836 Added 69.78%	48,264 $42.4 Million
Q2 2023 Aug 15, 2023	SELL	$700.03 - $830.35 $583,825 - $692,511	-834 Reduced 2.85%	28,428 $20.4 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $1.29 Million - $1.57 Million	1,899 Added 6.94%	29,262 $24 Million
Q4 2022 Feb 15, 2023	SELL	$705.89 - $766.39 $914,127 - $992,475	-1,295 Reduced 4.52%	27,363 $19.7 Million
Q3 2022 Jan 26, 2023	BUY	$573.97 - $724.32 $146,362 - $184,701	255 Added 0.9%	28,658 $19.7 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $556,026 - $749,183	1,014 Added 3.7%	28,403 $16.8 Million
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $1.44 Million - $1.69 Million	-2,423 Reduced 8.13%	27,389 $19.1 Million
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $38 Million - $47 Million	-69,978 Reduced 70.13%	29,812 $18.8 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $10.6 Million - $12.6 Million	18,478 Added 22.72%	99,790 $60.4 Million
Q2 2021 Aug 11, 2021	SELL	$472.8 - $558.54 $7.6 Million - $8.98 Million	-16,071 Reduced 16.5%	81,312 $45.4 Million
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $35.1 Million - $43.1 Million	78,564 Added 417.47%	97,383 $46.1 Million
Q4 2020 Feb 09, 2021	SELL	$478.3 - $607.98 $5 Million - $6.36 Million	-10,464 Reduced 35.73%	18,819 $9.09 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $814,946 - $984,682	-1,496 Reduced 4.86%	29,283 $16.4 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $2.43 Million - $3.18 Million	4,932 Added 19.08%	30,779 $19.2 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $2.29 Million - $3.37 Million	6,817 Added 35.82%	25,847 $12.6 Million
Q4 2019 Feb 06, 2020	SELL	$274.13 - $376.51 $219,578 - $301,584	-801 Reduced 4.04%	19,030 $7.15 Million
Q3 2019 Oct 30, 2019	BUY	$273.46 - $318.39 $467,616 - $544,446	1,710 Added 9.44%	19,831 $5.5 Million
Q2 2019 Aug 12, 2019	SELL	$299.6 - $414.82 $2.54 Million - $3.52 Million	-8,485 Reduced 31.89%	18,121 $5.67 Million
Q1 2019 May 13, 2019	SELL	$372.08 - $439.57 $14.1 Million - $16.6 Million	-37,807 Reduced 58.69%	26,606 $10.9 Million
Q4 2018 Feb 11, 2019	BUY	$335.82 - $403.04 $744,512 - $893,539	2,217 Added 3.56%	64,413 $24.1 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $15.3 Million - $17.8 Million	43,654 Added 235.43%	62,196 $25.1 Million
Q1 2018 May 11, 2018	SELL	$315.82 - $393.78 $1.31 Million - $1.63 Million	-4,152 Reduced 18.3%	18,542 $6.39 Million
Q4 2017 Feb 12, 2018	SELL	$358.63 - $469.95 $7.01 Million - $9.18 Million	-19,539 Reduced 46.26%	22,694 $8.53 Million
Q3 2017 Nov 01, 2017	BUY	$431.38 - $504.0 $18.2 Million - $21.3 Million	42,233	42,233 $18.9 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.

Account

State Of Tennessee, Treasury Department Regeneron Pharmaceuticals, Inc. Transaction History